We are live on ! Find out more
IBER.U

Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant
IBER.U

Delisted

IBER.U was delisted on the 1st of March, 2023.

Back to rankings

27 hedge funds and large institutions have $49.6M invested in Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

5% less capital invested

Capital invested by funds: $52.4M → $49.6M (-$2.81M)

21% less funds holding

Funds holding: 34 → 27 (-7)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

86% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 7

Holders
27
Holders Change
-7
Holders Change %
-20.59%
% of All Funds
0.47%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
1
Increased
3
Reduced
4
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OPU
Omni Partners US
California
+$186K
2
WAM
Wolverine Asset Management
Illinois
+$10.4K
3
Jane Street
Jane Street
New York
+$90

Top Sellers

Rank Fund Capital Flow
1
CCA
Castle Creek Arbitrage
Colorado
-$2.54M
2
Citadel Advisors
Citadel Advisors
Florida
-$2.29M
3
Millennium Management
Millennium Management
New York
-$1.95M
4
BCM
Basso Capital Management
Connecticut
-$1.36M
5
SSA
Schonfeld Strategic Advisors
New York
-$1.36M
Name Holding Trade Value Shares
Change 		Change in
Stake
HP
1
Hartree Partners
New York
$12.8M – – –
MF
2
Magnetar Financial
Illinois
$8.03M – – –
SCM
3
Shaolin Capital Management
Florida
$3.96M – – –
OPU
4
Omni Partners US
California
$3.83M +$186K +18,662 +5%
AC
5
Aristeia Capital
Connecticut
$3.5M – – –
WC
6
Wealthspring Capital
New York
$2.5M -$266K -26,690 -10%
Calamos Advisors
7
Calamos Advisors
Illinois
$2.5M – – –
PC
8
Periscope Capital
Ontario, Canada
$2.5M – – –
GCL
9
Glazer Capital LLC
New York
$2.11M -$143K -14,296 -6%
Millennium Management
10
Millennium Management
New York
$1.35M -$1.95M -195,383 -59%
CCM
11
Context Capital Management
California
$1.15M – – –
SMA
12
Sage Mountain Advisors
Georgia
$911K -$23.6K -2,370 -3%
Walleye Trading
13
Walleye Trading
New York
$800K – – –
HF
14
HRT Financial
New York
$649K – – –
Jane Street
15
Jane Street
New York
$565K +$90 +9 +0%
HP
16
Hound Partners
New York
$498K – – –
Janus Henderson Group
17
Janus Henderson Group
United Kingdom
$464K – – –
LCM
18
Landscape Capital Management
New Jersey
$366K – – –
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
$294K – – –
DIG
20
DeepCurrents Investment Group
New York
$177K – – –
BI
21
Bulldog Investors
New Jersey
$150K – – –
E
22
Ergoteles
New York
$138K – – –
HA
23
Harbor Advisors
Florida
$100K – – –
EH
24
EMG Holdings
Connecticut
$100K +$99.7K +10,000 New
WAM
25
Wolverine Asset Management
Illinois
$91K +$10.4K +1,041 +13%
1
2

IBER.U Hedge Fund Activity: Q3 2021 in Review

27 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant (IBER.U) for Q3 2021, worth a combined $49.6M — down 5.4% from $52.4M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of IBER.U and 1 opened new positions — a net loss of 6 holders — while 4 trimmed existing stakes and 3 added.

The largest buyer was Omni Partners US, adding an estimated $186K. The largest seller was Castle Creek Arbitrage, exiting entirely with an estimated $2.54M sold.

  • 27 institutional investors held Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant (IBER.U) as of Q3 2021, down from 34 in Q2 2021.
  • Funds reported $49.6M of Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant stock for Q3 2021, down 5.4% quarter-over-quarter.
  • 1 fund opened new Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant positions in Q3 2021 and 7 closed out, a net change of -6 holders.
  • The largest Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant buyer in Q3 2021 was Omni Partners US, an estimated $186K added.
  • The largest Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant seller in Q3 2021 was Castle Creek Arbitrage, an estimated $2.54M sold.

Based on aggregated 13F filings for Q3 2021.